, Tracking Stock Market Picks
Enter Symbol:
Oncolytics Biotech, Inc. (ONCY) [hlAlert]

down 90.71 %

Oncolytics Biotech, Inc. (ONCY) rated Outperform with price target $9 by Wedbush

Posted on: Wednesday,  Apr 13, 2011  9:25 AM ET by Wedbush

Wedbush rated Outperform Oncolytics Biotech, Inc. (NASDAQ: ONCY) on 04/13/2011, when the stock price was $5.71. Since
then, Oncolytics Biotech, Inc. has lost 90.72% as of 11/04/2015's recent price of $0.53.
If you would have followed this Wedbush 's recommendation on ONCY, you would have lost 90.71% of your investment in 1666 days.

Oncolytics Biotech, Inc. focuses on the discovery and development of pharmaceutical products for the treatment of a wide variety of human and companion pet cancers. The Company was formed to explore the oncolytic capability of the reovirus, a virus that preferentially replicates in cells with an activated Ras pathway, one of the most common family of genetic defects leading to cancer.

Wedbush is Headquartered in Los Angeles, California with over 90 offices and more than 125 correspondent offices, our commitment to providing relentless, customized service is the foundation of our consistent growth. We deliver superior investment ideas and products through exceptional customer care, financial security, continuity and advanced technology.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/13/2011 9:25 AM Buy
5.71 9.00
as of 12/30/2011
1 Week up  8.03 %
1 Month down  -6.02 %
3 Months up  12.06 %
1 YTD down  -31.69 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy